7MX2 image
Entry Detail
PDB ID:
7MX2
EMDB ID:
Keywords:
Title:
Cryo-EM structure of human ternary NatC complex with a Bisubstrate inhibitor
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2021-05-18
Release Date:
2022-12-14
Method Details:
Experimental Method:
Resolution:
3.64 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:N-alpha-acetyltransferase 30
Chain IDs:C (auth: A)
Chain Length:152
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:N-alpha-acetyltransferase 35, NatC auxiliary subunit
Chain IDs:A (auth: B)
Chain Length:725
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:N-alpha-acetyltransferase 38, NatC auxiliary subunit
Chain IDs:B (auth: C)
Chain Length:125
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:peptide portion of bisubstrate inhibitor
Chain IDs:D
Chain Length:4
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Molecular role of NAA38 in thermostability and catalytic activity of the human NatC N-terminal acetyltransferase.
Structure 31 166 173.e4 (2023)
PMID: 36638802 DOI: 10.1016/j.str.2022.12.008

Abstact

N-terminal acetylation occurs on over 80% of human proteins and is catalyzed by a family of N-terminal acetyltransferases (NATs). All NATs contain a small catalytic subunit, while some also contain a large auxiliary subunit that facilitates catalysis and ribosome targeting for co-translational acetylation. NatC is one of the major NATs containing an NAA30 catalytic subunit, but uniquely contains two auxiliary subunits, large NAA35 and small NAA38. Here, we report the cryo-EM structures of human NatC (hNatC) complexes with and without NAA38, together with biochemical studies, to reveal that NAA38 increases the thermostability and broadens the substrate-specificity profile of NatC by ordering an N-terminal segment of NAA35 and reorienting an NAA30 N-terminal peptide binding loop for optimal catalysis, respectively. We also note important differences in engagement with a stabilizing inositol hexaphosphate molecule between human and yeast NatC. These studies provide new insights for the function and evolution of the NatC complex.

Legend

Protein

Chemical

Disease

Primary Citation of related structures